The growth in demand for substance use disorder (SUD) treatment is likely to continue even if the economy enters into a recession. Beyond the epidemiology of substance abuse during recessionary periods, Federal legislation and state Medicaid policy remain consistent tailwinds to the industry. However, care must be taken in modeling commercial payor revenues, where an industry shift innetwork and the risk of high deductibles have added pressures to profitability. In this report, Marwood Group addresses the key tailwinds and challenges to this industry which has seen significant investor interest. Read more.
Growth and Consolidation in the Substance Use Disorder Treatment Space
